Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) - Investment analysts at HC Wainwright decreased their Q2 2027 earnings per share (EPS) estimates for Genmab A/S in a research note issued to investors on Friday, November 6th. HC Wainwright analyst R. Selvaraju now forecasts that the company will